Global Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial), Regional Forecasts 2021-2027

BIZ4599929
200 Pages
July 2021
Pharmaceuticals

Download Sample Get Discount

Global Vaccine Adjuvants Market is valued approximately at USD 0.70 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 10.5% over the forecast period 2021-2027. Vaccine adjuvant is an immunological agent that helps in the modification of other agents' effects. It is included in the vaccination to boost the immune response and provide long-lasting protection against the antigen. Adjuvants are added to vaccines to improve the body's response to vaccination while also reducing the number of vaccine doses given to patients. Aluminum hydroxide and paraffin oil are the most often utilized adjuvants. Vaccine adjuvant also decreases the quantity of administered foreign material. It has also been used in research and for commercial purposes. The market growth is driven by high prevalence of infectious and zoonotic diseases and increasing focus on immunization programs from various government bodies. For instance, various governmental organizations across the globe are promoting and creating awareness about vaccination against diseases such as anthrax, BCG, hepatitis, HPV, influenza, varicella, smallpox, and other illnesses. The US government provided USD 290 million in foreign aid to the Global Alliance for Vaccines and Immunization (GAVI, now known as GAVI, the Vaccine Alliance) in 2019 and USD 226 million to the Department of Health and Human Services (HHS) to support child vaccine campaigns in other countries. However, stringent regulatory environment and time-consuming approvals may impede market growth over the forecast period of 2021-2027.

A rise in investments for R&D of novel medicines, as well as an increase in deadly epidemic illnesses, are driving the vaccine adjuvants market in the North American area. As a result, vaccination against acute and chronic illnesses is required. In addition, the existence of significant market participants in the United States increases product penetration. Adjuvance Technologies, Inc., for example, has created a portfolio of adjuvants for the treatment of a variety of diseases.

Major market player included in this report are:

SPI Pharma, Inc.

Brenntag Biosector A/S

Seppic

CSL Limited

Agenus, Inc.

Novavax, Inc.

Invivogen

SPI Pharma, Inc. (A Subsidiary of Associated British Foods PLC.)

Avanti Polar Lipids, Inc.

MVP Laboratories, Inc.

OZ Biosciences

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product type:

Pathogen Components

Adjuvant Emulsions

Particulate Adjuvants

Combination Adjuvants

Others

By Route of administration:

Oral

Subcutaneous

Intranasal

Intramuscular

Intradermal

Others

By Application:

Research Applications

Commercial Applications

By Disease type:

Infectious Diseases

Cancer

Others

By Region:

North America

U.S.

Canada

Europe

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019

Base year – 2020

Forecast period – 2021 to 2027.

Target Audience of the Global Vaccine Adjuvants Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)

1.2.1. Vaccine Adjuvants Market, by Region, 2019-2027 (USD Billion)

1.2.2. Vaccine Adjuvants Market, by Product type, 2019-2027 (USD Billion)

1.2.3. Vaccine Adjuvants Market, by Route of administration, 2019-2027 (USD Billion)

1.2.4. Vaccine Adjuvants Market, by Application, 2019-2027 (USD Billion)

1.2.5. Vaccine Adjuvants Market, By Disease type, 2019-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Vaccine Adjuvants Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Vaccine Adjuvants Market Dynamics

3.1. Vaccine Adjuvants Market Impact Analysis (2019-2027)

3.1.1. Market Drivers

3.1.1.1. High prevalence of infectious and zoonotic diseases

3.1.1.2. Increasing focus on immunization programs from various government bodies

3.1.2. Market Restraint

3.1.2.1. Stringent regulatory environment and time-consuming approvals

3.1.2.2. High cost of adjuvant research

3.1.3. Market Opportunities

3.1.3.1. Pandemic diseases

3.1.3.2. Combination adjuvants

Chapter 4. Global Vaccine Adjuvants Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Vaccine Adjuvants Market, by Product type

5.1. Market Snapshot

5.2. Global Vaccine Adjuvants Market by Product type, Performance - Potential Analysis

5.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Product type 2018-2027 (USD Billion)

5.4. Vaccine Adjuvants Market , Sub Segment Analysis

5.4.1. Pathogen Components

5.4.2. Adjuvant Emulsions

5.4.3. Particulate Adjuvants

5.4.4. Combination Adjuvants

5.4.5. Others

Chapter 6. Global Vaccine Adjuvants Market, by Route of Administration

6.1. Market Snapshot

6.2. Global Vaccine Adjuvants Market by Route of Administration, Performance - Potential Analysis

6.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Route of administration 2018-2027 (USD Billion)

6.4. Vaccine Adjuvants Market , Sub Segment Analysis

6.4.1. Oral

6.4.2. Subcutaneous

6.4.3. Intranasal

6.4.4. Intramuscular

6.4.5. Intradermal

6.4.6. Others

Chapter 7. Global Vaccine Adjuvants Market, by Disease type

7.1. Market Snapshot

7.2. Global Vaccine Adjuvants Market by Disease type, Performance - Potential Analysis

7.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Disease type 2018-2027 (USD Billion)

7.4. Vaccine Adjuvants Market , Sub Segment Analysis

7.4.1. Research Applications

7.4.2. Commercial Applications

Chapter 8. Global Vaccine Adjuvants Market, by Application

8.1. Market Snapshot

8.2. Global Vaccine Adjuvants Market by Application, Performance - Potential Analysis

8.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Application 2018-2027 (USD Billion)

8.4. Vaccine Adjuvants Market , Sub Segment Analysis

8.4.1. Research and Development

8.4.2. Clinical Diagnostics

Chapter 9. Global Vaccine Adjuvants Market, Regional Analysis

9.1. Vaccine Adjuvants Market , Regional Market Snapshot

9.2. North America Vaccine Adjuvants Market

9.2.1. U.S. Vaccine Adjuvants Market

9.2.1.1. Product type breakdown estimates & forecasts, 2018-2027

9.2.1.2. Route of administration breakdown estimates & forecasts, 2018-2027

9.2.1.3. Disease type breakdown estimates & forecasts, 2018-2027

9.2.1.4. Application breakdown estimates & forecasts, 2018-2027

9.2.2. Canada Vaccine Adjuvants Market

9.3. Europe Vaccine Adjuvants Market Snapshot

9.3.1. U.K. Vaccine Adjuvants Market

9.3.2. Germany Vaccine Adjuvants Market

9.3.3. France Vaccine Adjuvants Market

9.3.4. Spain Vaccine Adjuvants Market

9.3.5. Italy Vaccine Adjuvants Market

9.3.6. Rest of Europe Vaccine Adjuvants Market

9.4. Asia-Pacific Vaccine Adjuvants Market Snapshot

9.4.1. China Vaccine Adjuvants Market

9.4.2. India Vaccine Adjuvants Market

9.4.3. Japan Vaccine Adjuvants Market

9.4.4. Australia Vaccine Adjuvants Market

9.4.5. South Korea Vaccine Adjuvants Market

9.4.6. Rest of Asia Pacific Vaccine Adjuvants Market

9.5. Latin America Vaccine Adjuvants Market Snapshot

9.5.1. Brazil Vaccine Adjuvants Market

9.5.2. Mexico Vaccine Adjuvants Market

9.6. Rest of The World Vaccine Adjuvants Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies

10.2. Company Profiles

10.2.1. SPI Pharma, Inc.

10.2.1.1. Key Information

10.2.1.2. Overview

10.2.1.3. Financial (Subject to Data Availability)

10.2.1.4. Product Summary

10.2.1.5. Recent Developments

10.2.2. Brenntag Biosector A/S

10.2.3. Seppic

10.2.4. CSL Limited

10.2.5. Agenus, Inc.

10.2.6. Novavax, Inc.

10.2.7. Invivogen

10.2.8. SPI Pharma, Inc. (A Subsidiary of Associated British Foods PLC.)

10.2.9. Avanti Polar Lipids, Inc.

10.2.10. MVP Laboratories, Inc.

10.2.11. OZ Biosciences

Chapter 11. Research Process

11.1. Research Process

11.1.1. Data Mining

11.1.2. Analysis

11.1.3. Market Estimation

11.1.4. Validation

11.1.5. Publishing

11.2. Research Attributes

11.3. Research Assumption

List of Tables

TABLE 1. Global Vaccine Adjuvants Market, report scope

TABLE 2. Global Vaccine Adjuvants Market estimates & forecasts by region 2018-2027 (USD Billion)

TABLE 3. Global Vaccine Adjuvants Market estimates & forecasts by Product type 2018-2027 (USD Billion)

TABLE 4. Global Vaccine Adjuvants Market estimates & forecasts by Route of administration 2018-2027 (USD Billion)

TABLE 5. Global Vaccine Adjuvants Market estimates & forecasts by Disease type 2018-2027 (USD Billion)

TABLE 6. Global Vaccine Adjuvants Market estimates & forecasts by Application 2018-2027 (USD Billion)

TABLE 7. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 8. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 9. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 10. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 11. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 12. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 13. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 14. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 15. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 16. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 17. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 18. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 19. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 20. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 21. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 22. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 23. U.S. Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 24. U.S. Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 25. U.S. Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 26. Canada Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 27. Canada Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 28. Canada Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 29. UK Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 30. UK Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 31. UK Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 32. Germany Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 33. Germany Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 34. Germany Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 35. France Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 36. France Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 37. France Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 38. Spain Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 39. Spain Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 40. Spain Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 41. Italy Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 42. Italy Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 43. Italy Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 44. ROE Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 45. ROE Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 46. ROE Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 47. China Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 48. China Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 49. China Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 50. India Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 51. India Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 52. India Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 53. Japan Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 54. Japan Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 55. Japan Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 56. Australia Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 57. Australia Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 58. Australia Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 59. South Korea Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 60. South Korea Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 61. South KoreaVaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 62. ROPAC Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 63. ROPAC Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 64. ROPAC Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 65. Brazil Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 66. Brazil Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 67. Brazil Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 68. Mexico Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 69. Mexico Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 70. Mexico Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 71. ROLA Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 72. ROLA Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 73. ROLA Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 74. ROW Vaccine Adjuvants Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 75. ROW Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 76. ROW Vaccine Adjuvants Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 77. List of secondary sources used in the study of Global Vaccine Adjuvants Market.

TABLE 78. List of primary sources used in the study of Global Vaccine Adjuvants Market.

TABLE 79. Years considered for the study.

TABLE 80. Exchange rates considered.

Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Global Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial), Regional Forecasts 2021-2027

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara